Capricor Therapeutics
Capricor Therapeutics is providing CAP-1002, its novel cell therapy to patients with advanced COVID-19 under the compassionate use pathway
Rankings by
National Ranking235th
in United States Regional Ranking262nd
in North America and Caribbean Global Ranking646th
worldwide